COVID – 19 | Vaccination Update – Day 620

0
39
Should doctors accept unvaccinated children as patients
Should doctors accept unvaccinated children as patients

India’s COVID-19 vaccination coverage has crossed 217.94 Crore (2,17,94,27,825today. More than 10 lakh (10,89,454) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10415081
2nd Dose 10117932
Precaution Dose 6998218
FLWs 1st Dose 18436609
2nd Dose 17715337
Precaution Dose 13606619
Age Group 12-14 years 1st Dose 40971571
  2nd Dose 31607999
Age Group 15-18 years 1st Dose 61927363
  2nd Dose 53000800
Age Group 18-44 years 1st Dose 561225653
2nd Dose 515564447
Precaution Dose 92007770
Age Group 45-59 years 1st Dose 204021015
2nd Dose 196920225
Precaution Dose 47404548
Over 60 years 1st Dose 127663021
2nd Dose 123110912
Precaution Dose 46712705
Cumulative 1st dose administered 1024660313
Cumulative 2nd dose administered 948037652
Precaution Dose 206729860
Total 2179427825

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 27th September, 2022 (620th Day)
HCWs 1st Dose 13
2nd Dose 147
Precaution Dose 6120
FLWs 1st Dose 30
2nd Dose 447
Precaution Dose 9615
Age Group 12-14 years 1st Dose 12198
  2nd Dose 26158
Age Group 15-18 years 1st Dose 3741
  2nd Dose 12700
Age Group 18-44 years 1st Dose 9685
2nd Dose 37704
Precaution Dose 601936
Age Group 45-59 years 1st Dose 1587
2nd Dose 7863
Precaution Dose 244856
Over 60 years 1st Dose 1346
2nd Dose 5749
Precaution Dose 107559
Cumulative 1st dose administered 28600
Cumulative 2nd dose administered 90768
Precaution Dose 970086
Total 1089454

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

****